Abstract
Assessment of therapy efficacy using animal models of tumorigenic cancer requires the ability to accurately measure changes in tumor volume over the duration of disease course. In order to be meaningful, in vivo tumor volume measurements by non-invasive techniques must correlate with tumor volume measurements from endpoint histological analysis. Tumor volume is frequently assessed by endpoint histological analyses approximating the tumor volume with geometric primitives such as spheroids and ellipsoids. In this study we investigated alternative techniques for quantifying histological volume measurements of tumors in a xenograft orthotopic mouse model of human glioblastoma multiforme, and compared these to in vivo tumor volume measurements based on magnetic resonance imaging (MRI) data. Two techniques leveraging three-dimensional (3D) image analysis methods were investigated. The first technique involves the reconstruction of a smoothed polygonal model representing the tumor volume from histological section images and is intended for accuracy and qualitative assessment of tumor burden by visualization, while a second technique which approximates the tumor volume as a series of slabs is presented as an abbreviated process intended to produce quantitatively similar volume measurements with a minimum of effort required on behalf of the investigator. New software (QuickVol) designed for use in the first technique, is also discussed. In cases where tumor growth is asymmetric and invasive, we found that 3D analysis techniques using histological section images produced volume measurements more consistent with in vivo volume measurements based on MRI data, than approximation of tumor volume using geometric primitives. Visualizations of the volumes represented by each of these techniques qualitatively support this finding, and suggest that future research using mouse models of glioblastoma multiforme (genetically engineered or xenograft) will benefit from the use of these or similar alternative tumor volume measurement techniques.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Holland EC: Glioblastoma multiforme: the terminator. Proc Natl Acad Sci USA 97: 6242–6244, 2000
Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46(2): 183–188, 1999
Giese A, Westphal M: Glioma Invasion in the Central Nervous System. Neurosurgery 39(2): 235–250, 1996
Giese A, Bjerkvig R, Berens ME, Westphal M: Cost of migration: invasion of malignant gliomas and implication for treatment. J Clin Oncol 21(8): 1624–1636, 2003
Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M, Rosen EM: Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer USA 75(1): 19–28, 1998
Holland EC: Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2(2): 120–129, 2001
Dai C, Holland EC: Glioma models. Biochim Biophys Acta 1551(1): M19–M27, 2001
Giussani C, Carrabba G, Pluderi M, Lucini V, Pannacci M, Caronzolo D, Costa F, Minotti M, Tomei G, Villani R, Carroll RS, Bikfalvi A, Bello L: Local intracerebral delivery of endogenous inhibitors by osmotic minipumps effectively suppresses glioma growth in vivo. Cancer Res 63(10): 2499–2505, 2003
Takano S, Tsuboi K, Matsumura A, Nose T: Antivascular endothelial growth factor antibody and nimustine as combined therapy: effects on tumour growth and angiogenesis in human glioblastoma xenografts. Neuro-Oncol 5(1): 1–7, 2003
Eshleman JS, Carlson BL, Mladek AC, Kastner BD, Shide KL, Sarkaria JN: Inhibition of the mammalian target of rapamhcin sensitizes U87 Xenografts to fractionaltd radiation therapy. Cancer Res 62(24): 7291–7297, 2002
Nylandsted J, Wick W, Hirt UA, Brand K, Rohde M, Leist M, Weller M, Jaattela M: Eradication of glioblastoma, and breast and colon carcinoma xenografts by Hsp70 depletion. Cancer Res 62(24): 7139–7142, 2002
Fulda S, Wick W, Weller M, Debatin KM: Smac agonists sensitize for Apo2L/TRAIL-or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8(8): 808–815, 2002
Peroulis I, Jonas N, Saleh M: Antiangiogenic activity of endostatin inhibits C6 glioma growth. Int J Cancer 97(6): 839–845, 2002
Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM: Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 61(24): 8730–8736, 2001
Reilly KM, Jacks T: Genetically engineered mouse models of astrocytoma: GEMs in the rough? Semin Cancer Biol 11(3): 177–191, 2001
Pollack IF, Erff M, Bom D, Burke TG, Strode JT, Curran DP: Potent topoisomerase I inhibition by novel silatecans eliminates glioma proliferation in vitro and in vivo. Cancer Res 59(19): 4898–4905, 1999
Mukai S, Kjaergaard J, Shu S, Plautz GE: Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res 59(20): 5245–5249, 1999
Advani SJ, Chung SM, Yan SY, Gillespie GY, Markert JM, Whitley RJ, Roizman B, Weichselbaum RR: Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res 59(9): 2055–2058, 1999
Somville J, De Beuckeleer L, De Schepper A, Verstreken J, Taminiau A: Reliability of measuring volume by different methods for tumors of the musculoskeltal system. Acta Orthop Belg 67(4): 338–343, 2001
Ernestus RI, Wilmes LJ, Hoehn-Berlage M: Identification of intracranial liqor metastases of experimental stereotactically implanted brain tumors by the tumor-selective MRI contrast agent MnTPPS. Clin Exp Metastasis 10(5): 345–350, 1992
Weisstein EW: CRC Concise Encyclopedia of Mathematics, 2nd edn. CRC Press, Inc., Boca Raton, FL, 2002
Tallarida R: Pocket Book of Integrals and Mathematical Formulas, 2nd edn. CRC Press, Inc., Boca Raton, FL, 1992, pp 12-14
Watt A, Watt M: Advanced Animation and Rendering Techniques. Addison-Wesley, New York, 1992, pp 302-304
Lorensen W, Cline H: Marching cubes: a high resolution 3d surface construction algorithm. Comp Graph 21(3): 163–169, 1987
Runyon R, Haber A: Fundamentals of Behavioral Statistics, 4th edn, Addison-Wesley Publishing Company, Reading, MA, 1980, pp 123-124
Gering D, Nabavi A, Kikinis R, Eric W, Grimson L, Hata N, Everett P, Jolesz F, Wells III W: An integrated visualization system for surgical planning and guidance using image fusion and interventional imaging. Medical Image Computing and Computer-Assisted Intervention (MICCAI), September 19–22, 1999, NeuroMedia Group, University of Kent at Canterbury, Cambridge, England, 1999
Galloway RL Jr, Maciunas RJ, Failinger AL: Factors affecting perceived tumor volumes in magnetic resonance imaging. Ann Biomed Eng 21(4): 367–375, 1993
Wree A, Goller HJ, Beck T: Local cerebral glucose utilization in perfusion — fixed rat brains. J Neurosci Methods 58(2): 143–149, 1995
Gonzalez Ballester MA, Zisserman AP, Brady M: Estimation of the partial volume effect in MRI. Med Image Anal 6(4): 389–405, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmidt, K.F., Ziu, M., Ole Schmidt, N. et al. Volume Reconstruction Techniques Improve the Correlation Between Histological and in vivo Tumor Volume Measurements in Mouse Models of Human Gliomas. J Neurooncol 68, 207–215 (2004). https://doi.org/10.1023/B:NEON.0000033364.43142.bf
Issue Date:
DOI: https://doi.org/10.1023/B:NEON.0000033364.43142.bf